211364-06-6
Catalog No.:AA01V7EQ

211364-06-6 | AT-130

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$73.00   $51.00
- +
5mg
≥98%
in stock  
$309.00   $216.00
- +
10mg
≥98%
in stock  
$506.00   $354.00
- +
25mg
≥98%
in stock  
$1,083.00   $758.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01V7EQ
Chemical Name:
AT-130
CAS Number:
211364-06-6
Molecular Formula:
C22H22BrN3O5
Molecular Weight:
488.3312
SMILES:
COc1ccccc1/C(=C(/C(=O)N1CCCCC1)\NC(=O)c1ccc(cc1)[N+](=O)[O-])/Br
Properties

Literature

Title: William E Delaney 4th, et al. Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro. Antimicrob Agents Chemother. 2002 Sep;46(9):3057-60.

Title: R B Perni , et al. Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. Bioorg Med Chem Lett. 2000 Dec 4;10(23):2687-90.

Title: J J Feld, et al. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging. Antiviral Res. 2007 Nov;76(2):168-77.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 211364-06-6
Building Blocks
More >
Tags:211364-06-6 Molecular Formula|211364-06-6 MDL|211364-06-6 SMILES|211364-06-6 AT-130
Catalog No.: AA01V7EQ
211364-06-6
211364-06-6 | AT-130
Pack Size: 1mg
Purity: ≥98%
in stock
$73.00 $51.00
Pack Size: 5mg
Purity: ≥98%
in stock
$309.00 $216.00
Pack Size: 10mg
Purity: ≥98%
in stock
$506.00 $354.00
Pack Size: 25mg
Purity: ≥98%
in stock
$1,083.00 $758.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01V7EQ
Chemical Name: AT-130
CAS Number: 211364-06-6
Molecular Formula: C22H22BrN3O5
Molecular Weight: 488.3312
SMILES: COc1ccccc1/C(=C(/C(=O)N1CCCCC1)\NC(=O)c1ccc(cc1)[N+](=O)[O-])/Br
Properties
Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.